Gao et al. explored the role of CDK5 in lung adenocarcinoma and found that CDK5 inhibition led to a reduction in PD-L1 protein levels via the ubiquitination–proteasome pathway mediated by TRIM21 [68]. Here, CDK5 is linked to lung adenocarcinoma.